Novartis AG is 96.8x more valuable than Dyne Therapeutics, Inc. by market capitalization ($282.64 B vs $2.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DYN | NVS |
|---|---|---|
| Market cap | $2.92 B | $282.64 B |
| US-listed rank | #1827 | #47 |
| Net income (latest FY) | -$446.20 | - |
| SEC filings | 710 | 947 |
Novartis AG is 96.8x more valuable than Dyne Therapeutics, Inc. by market capitalization ($282.64 B vs $2.92 B).
Full pages: Dyne Therapeutics, Inc. and Novartis AG, or browse the full rankings.